For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

Institute of Cancer Research

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo

Type
D - Journal article
Title of journal
Clinical Cancer Research
Article number
-
Volume number
19
Issue number
21
First page of article
5940
ISSN of journal
1557-3265
Year of publication
2013
Number of additional authors
14
Additional information
-
Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
1
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-